Or. Admin. Code § 850-060-0223

Current through Register Vol. 63, No. 12, December 1, 2024

Section 850-060-0223 - Formulary Compendium Exclusions

The Formulary Council has approved substances as listed by classification in 850-060-0226 for use by Naturopathic physicians in accordance with professional standards of care.

(1) This authority does not supersede the education and training requirement established in 850-060-0212 for administration of IV agents or any other education and training required to prescribe, dispense, administer, or order all legend or controlled substances.

(2) Additionally, the following substances may not be prescribed by licensees of this Board.

(a) General anesthetics

(b) Injectable Ketamine for the purpose of general anesthesia

(c) Mifepristone and Misoprostol as an abortifacient

(d) Barbiturates; with the exception of the following:

(A) Phenobarbital

(B) Butalbital

(C) Primidone

(e) Systemic oncology agents with the exception of the following antineoplastic agents, in oral and topical form only.

(A) 5FU

(B) Anastrozole

(C) Letrozole

(D) Mechlorethamine

(E) Megestrol

(F) Mercaptopurine

(G) Methotrexate

(H) Tamoxifen

(I) Tretinoin

(f) Any other substance not listed in 850-060-0226 classification or meeting prior approval of the Board.

Or. Admin. Code § 850-060-0223

OBNM 4-2016, f. & cert. ef. 10/12/2016; OBNM 1-2018, amend filed 02/16/2018, effective 2/16/2018; OBNM 5-2018, amend filed 12/20/2018, effective 12/20/2018; OBNM 13-2022, amend filed 12/13/2022, effective 1/1/2023; OBNM 1-2023, temporary amend filed 01/20/2023, effective 1/20/2023through 7/17/2023; OBNM 2-2023, amend filed 06/23/2023, effective 6/23/2023

Statutory/Other Authority: ORS 685.125

Statutes/Other Implemented: ORS 685.030